• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevalence, incidence and persistence of ADHD drug use in Japan.

作者信息

Okumura Y, Usami M, Okada T, Saito T, Negoro H, Tsujii N, Fujita J, Iida J

机构信息

Research Department, Institute for Health Economics and Policy, Association for Health Economics Research and Social Insurance and Welfare, Tokyo, Japan.

Department of Psychiatry and Behavioral Science, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.

出版信息

Epidemiol Psychiatr Sci. 2019 Dec;28(6):692-696. doi: 10.1017/S2045796018000252. Epub 2018 May 28.

DOI:10.1017/S2045796018000252
PMID:29804548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6998865/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb4a/7032519/ec39f4eba219/S2045796018000252_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb4a/7032519/ec39f4eba219/S2045796018000252_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb4a/7032519/ec39f4eba219/S2045796018000252_fig1.jpg

相似文献

1
Prevalence, incidence and persistence of ADHD drug use in Japan.日本注意力缺陷多动障碍（ADHD）药物使用的患病率、发病率和持续时间。
Epidemiol Psychiatr Sci. 2019 Dec;28(6):692-696. doi: 10.1017/S2045796018000252. Epub 2018 May 28.
2
Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011.2007 - 2011年韩国儿童和青少年注意力缺陷多动障碍药物的处方模式
Epidemiol Health. 2016 Oct 26;38:e2016045. doi: 10.4178/epih.e2016045. eCollection 2016.
3
Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.哌甲酯和托莫西汀用于注意缺陷多动障碍（ADHD）儿童的安全性：来自意大利国家ADHD注册研究的数据
CNS Drugs. 2015;29(10):865-77. doi: 10.1007/s40263-015-0266-7.
4
Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.治疗患有注意力缺陷多动障碍的儿童和青少年的医生的护理提供与处方实践。
Psychiatr Serv. 2017 Jul 1;68(7):681-688. doi: 10.1176/appi.ps.201600130. Epub 2017 Feb 15.
5
Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.与 ADHD 药物处方相关的患者和提供者特征：韩国全国健康保险索赔数据库研究。
Asia Pac Psychiatry. 2018 Mar;10(1). doi: 10.1111/appy.12289. Epub 2017 Jun 20.
6
Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.注意缺陷多动障碍药物使用趋势：一项基于人群数据库的回顾性观察研究
Lancet Psychiatry. 2018 Oct;5(10):824-835. doi: 10.1016/S2215-0366(18)30293-1. Epub 2018 Sep 13.
7
ADHD Medication Trends in Turkey: 2009-2013.土耳其注意缺陷多动障碍药物使用趋势：2009-2013 年。
J Atten Disord. 2017 Dec;21(14):1192-1197. doi: 10.1177/1087054714523129. Epub 2014 Jan 1.
8
Prescribing patterns for attention deficit hyperactivity disorder among children and adolescents in Taiwan from 2004 to 2017.2004 年至 2017 年台湾地区儿童和青少年注意缺陷多动障碍的处方模式。
J Formos Med Assoc. 2023 Jun;122(6):514-517. doi: 10.1016/j.jfma.2023.02.013. Epub 2023 Mar 15.
9
Prescribing for ADHD in primary care.基层医疗中多动症的处方开具
Br J Gen Pract. 2018 Apr;68(669):170-171. doi: 10.3399/bjgp18X695357.
10
Prevalence rates of youths diagnosed with and medicated for ADHD in a nationwide survey in Taiwan from 2000 to 2011.2000 年至 2011 年在台湾进行的一项全国性调查中被诊断和用药物治疗 ADHD 的青少年的患病率。
Epidemiol Psychiatr Sci. 2017 Dec;26(6):624-634. doi: 10.1017/S2045796016000500. Epub 2016 Jul 20.

引用本文的文献

1
Persistence with daily growth hormone among children and adolescents with growth hormone deficiency in Japan.日本生长激素缺乏症儿童和青少年每日生长激素治疗的持续性
PLoS One. 2025 Aug 14;20(8):e0324728. doi: 10.1371/journal.pone.0324728. eCollection 2025.
2
Lifetime risk, sex and age differences in annual incidence of ocular motor cranial nerve palsy in Japan for 2019.2019年日本动眼神经麻痹年发病率的终生风险、性别和年龄差异。
Commun Med (Lond). 2025 Jul 19;5(1):299. doi: 10.1038/s43856-025-01027-x.
3
Efficacy and safety of SDT-001, a dual-task digital device, in managing attention-deficit/hyperactivity disorder symptoms in children and adolescents: a phase 3, randomized, standard treatment-controlled study.

本文引用的文献

1
ADHD in Germany: Trends in Diagnosis and Pharmacotherapy.德国的注意缺陷多动障碍：诊断和药物治疗趋势。
Dtsch Arztebl Int. 2017 Mar 3;114(9):141-148. doi: 10.3238/arztebl.2017.0141.
2
Epidemiology of overdose episodes from the period prior to hospitalization for drug poisoning until discharge in Japan: An exploratory descriptive study using a nationwide claims database.日本从药物中毒住院前到出院期间药物过量事件的流行病学：一项使用全国索赔数据库的探索性描述性研究。
J Epidemiol. 2017 Aug;27(8):373-380. doi: 10.1016/j.je.2016.08.010. Epub 2017 Feb 24.
3
Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.
双重任务数字设备SDT-001治疗儿童和青少年注意力缺陷/多动障碍症状的疗效和安全性：一项3期随机标准治疗对照研究
Psychiatry Clin Neurosci. 2025 May 2. doi: 10.1111/pcn.13833.
4
Investigating Variations in Medicine Approvals for Attention-Deficit/Hyperactivity Disorder: A Cross-Country Document Analysis Comparing Drug Labeling.调查注意力缺陷/多动障碍药物批准的差异：比较药物标签的跨国文件分析
J Atten Disord. 2024 Sep;28(11):1437-1453. doi: 10.1177/10870547231224088. Epub 2024 Feb 7.
5
Practical clinical guidelines and pharmacological treatment for attention-deficit hyperactivity disorder in Asia.亚洲注意力缺陷多动障碍的实用临床指南及药物治疗
Neuropsychopharmacol Rep. 2024 Mar;44(1):29-33. doi: 10.1002/npr2.12381. Epub 2023 Dec 7.
6
Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort study.注意缺陷多动障碍儿童和青少年中渗透释放口腔系统哌甲酯的剂量滴定：回顾性队列研究。
BMC Pediatr. 2023 Jan 23;23(1):38. doi: 10.1186/s12887-023-03850-4.
7
Incidence of central serous chorioretinopathy (2011-2018): a nationwide population-based cohort study of Japan.中心性浆液性脉络膜视网膜病变的发病率（2011-2018 年）：日本一项基于全国人口的队列研究。
Br J Ophthalmol. 2022 Dec;106(12):1748-1753. doi: 10.1136/bjophthalmol-2021-319403. Epub 2021 Jul 14.
8
Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance.日本注意缺陷多动障碍药物治疗：标签依从性的回顾性队列研究。
Neuropsychopharmacol Rep. 2021 Sep;41(3):385-392. doi: 10.1002/npr2.12191. Epub 2021 Jun 28.
9
Current use of attention-deficit hyperactivity disorder (ADHD) medications and clinical characteristics of child and adolescent psychiatric outpatients prescribed multiple ADHD medications in Japan.日本儿童和青少年精神科门诊患者中 ADHD 药物的使用现状及同时开具多种 ADHD 药物的患者的临床特征。
PLoS One. 2021 Jun 3;16(6):e0252420. doi: 10.1371/journal.pone.0252420. eCollection 2021.
10
Risk factors for low adherence to methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder.注意缺陷多动障碍儿童患者对哌醋甲酯治疗低依从性的风险因素。
Sci Rep. 2021 Jan 18;11(1):1707. doi: 10.1038/s41598-021-81416-z.
利用基于人群的纵向数据对540万儿童使用兴奋剂和托莫西汀治疗注意力缺陷/多动障碍的情况进行研究。
Basic Clin Pharmacol Toxicol. 2017 Apr;120(4):373-379. doi: 10.1111/bcpt.12724. Epub 2017 Jan 30.
4
Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan.台湾多动症青少年药物治疗的起始与持续情况
PLoS One. 2016 Aug 12;11(8):e0161061. doi: 10.1371/journal.pone.0161061. eCollection 2016.
5
Prevalence rates of youths diagnosed with and medicated for ADHD in a nationwide survey in Taiwan from 2000 to 2011.2000 年至 2011 年在台湾进行的一项全国性调查中被诊断和用药物治疗 ADHD 的青少年的患病率。
Epidemiol Psychiatr Sci. 2017 Dec;26(6):624-634. doi: 10.1017/S2045796016000500. Epub 2016 Jul 20.
6
Trends in Stimulant Medication Use in Commercially Insured Youths and Adults, 2010-2014.2010 - 2014年商业保险覆盖的青少年和成年人中兴奋剂药物使用趋势
JAMA Psychiatry. 2016 Sep 1;73(9):992-3. doi: 10.1001/jamapsychiatry.2016.1182.
7
Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence.英国儿童注意力缺陷多动障碍（ADHD）药物处方模式的最新趋势：患病率、发病率和持续性。
BMJ Open. 2016 Jun 13;6(6):e010508. doi: 10.1136/bmjopen-2015-010508.
8
A Regional ADHD Center-Based Network Project for the Diagnosis and Treatment of Children and Adolescents With ADHD.区域性注意缺陷多动障碍中心网络项目：为儿童和青少年注意缺陷多动障碍的诊断和治疗提供服务。
J Atten Disord. 2018 Oct;22(12):1173-1184. doi: 10.1177/1087054715599573. Epub 2015 Aug 28.
9
Psychotropic medicine prescriptions in Italian youths: a multiregional study.意大利青少年的精神药物处方：一项多地区研究。
Eur Child Adolesc Psychiatry. 2016 Mar;25(3):235-45. doi: 10.1007/s00787-015-0726-0. Epub 2015 May 28.
10
Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.注意缺陷多动障碍患病率的系统评价和荟萃分析。
Pediatrics. 2015 Apr;135(4):e994-1001. doi: 10.1542/peds.2014-3482. Epub 2015 Mar 2.